Insider Trading

Notable insider buying and selling activity across public companies.

Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.

Articles

13,303 total articles

Planet Labs CEO Offloads $5.18M in Equity Under Pre-Arranged Plan

Planet Labs CEO Offloads $5.18M in Equity Under Pre-Arranged Plan

Marshall William Spencer, co-founder and chief executive officer of Planet Labs PBC, executed a sale of 200,000 shares of the company’s Class A Common Stock on July 10, 2026. The transaction, valued at approximately $5,183,940, was conducted under a Rule 10b5-1 trading plan established on July 12, 2025. The sale occurred at a weighted average price…

Heartflow Executive Unloads Shares Under Pre-Arranged Plan

Heartflow Executive Unloads Shares Under Pre-Arranged Plan

Heartflow Inc. CEO John C.M. Farquhar executed a sale of 22,562 shares on July 10, 2026, totaling $626,095 at $27.75 per share. This transaction occurred under a Rule 10b5-1 plan established in September 2025. The sale coincides with positive financial developments, including a first-quarter 2026 earnings beat and a sustained Overweight rating from…

Kodiak Gas Services Executive Offloads Shares Under Pre-Arranged Plan

Kodiak Gas Services Executive Offloads Shares Under Pre-Arranged Plan

William Chad Lenamon, Executive Vice President and Chief Operating Officer at Kodiak Gas Services, Inc. (NASDAQ:KGS), sold 1,000 shares of company stock on July 13, 2026, generating proceeds of $67,790. The transaction was executed at $67.79 per share through a 10b5-1 trading plan established on March 13, 2026. Following the sale, Lenamon retains d…

Silver Lake Affiliates Execute $15.8 Million Dell Stock Sale Following Class B to Class C Conversion

Silver Lake Affiliates Execute $15.8 Million Dell Stock Sale Following Class B to Class C Conversion

Entities affiliated with Silver Lake Partners and Dell Technologies director Egon Durban executed the sale of approximately $15.8 million in Class C Common Stock on July 9, 2026. The transaction followed the conversion of Class B shares into Class C shares, a mechanism allowing holders to liquidate equity without regulatory restrictions on direct C…

Silver Lake and Director Egon Durban Liquidate $26.98M in Dell Technologies Shares Amid Market Momentum

Silver Lake and Director Egon Durban Liquidate $26.98M in Dell Technologies Shares Amid Market Momentum

Silver Lake Group, L.L.C., alongside Dell Technologies director Egon Durban and related affiliated entities, executed a series of sales involving Dell Technologies Inc. Class C Common Stock, realizing approximately $26.98 million in value. These transactions, recorded on July 9, 2026, involved the disposal of 59,892 shares at weighted average price…

Arcus Biosciences President Juan C. Jaen Executes $2.03 Million Share Sale Under Pre-arranged Plan

Arcus Biosciences President Juan C. Jaen Executes $2.03 Million Share Sale Under Pre-arranged Plan

Juan C. Jaen, President of Arcus Biosciences (NASDAQ:RCUS), completed the sale of 68,569 shares over two days in July 2026, generating approximately $2.03 million. The transactions were executed via a Rule 10b5-1 trading plan, a mechanism designed to allow insiders to trade shares according to a predetermined schedule. This activity follows a signi…

Everpure Director Offloads Equity Stake Amid Analyst Optimism

Everpure Director Offloads Equity Stake Amid Analyst Optimism

Director Susan J.S. Taylor executed a significant equity sale in Everpure, Inc. (NASDAQ:P) on July 9, 2026, divesting 8,543 shares at $81.74 per share. The transaction, valued at $698,304, occurs as the stock trades below the sale price, reflecting a complex dynamic between insider activity and broader market valuation metrics. This move follows a …

PTC Therapeutics Director Mary L. Smith Executes Rule 10b5-1 Transactions Amid Strong Analyst Sentiment

PTC Therapeutics Director Mary L. Smith Executes Rule 10b5-1 Transactions Amid Strong Analyst Sentiment

PTC Therapeutics director Mary L. Smith executed a series of transactions on July 9, 2026, selling 15,834 shares valued at approximately $1.43 million. The sales followed the exercise of stock options on the same date, all conducted under a pre-arranged Rule 10b5-1 trading plan established in November 2025. This activity occurs against a backdrop o…